MétaCan
Menu
Back to cohort
Record W4403840993 · doi:10.1183/13993003.01050-2024

Targeting neutrophil serine proteases in bronchiectasis

2024· review· en· W4403840993 on OpenAlexfundno aff
James D. Chalmers, Marcus Mall, Sanjay H. Chotirmall, Anne E. O’Donnell, Patrick A. Flume, Naoki Hasegawa, Felix C. Ringshausen, Henrik Watz, Jin‐Fu Xu, Michal Shteinberg, Pamela J. McShane

Bibliographic record

VenueEuropean Respiratory Journal · 2024
Typereview
Languageen
FieldMedicine
TopicNeonatal Respiratory Health Research
Canadian institutionsnot available
FundersNational Medical Research CouncilUniversity of North Carolina at Chapel HillGrifolsSchool of Medicine, New York UniversityShionogiMannKind CorporationEuropean Federation of Pharmaceutical Industries and AssociationsVertex PharmaceuticalsDeutsches Zentrum für InfektionsforschungGenentechUniversity of DundeeDeutsches Zentrum für LungenforschungPfizerYork UniversityAstraZenecaChiesi FarmaceuticiCSL BehringBundesministerium für Bildung und ForschungINOVIO PharmaceuticalsInsmedMedical Research CouncilTeva Pharmaceutical IndustriesSanofiDeutsche ForschungsgemeinschaftArrowhead PharmaceuticalsGlaxoSmithKlineGilead SciencesBoehringer Ingelheim
KeywordsMedicineCathepsin GNeutrophil elastaseProteinase 3ProteasesInflammationPathogenesisBronchiectasisImmunologyElastaseNeutrophil extracellular trapsLungMyeloperoxidaseInternal medicineEnzymeBiology

Abstract

fetched live from OpenAlex

Persistent neutrophilic inflammation is a central feature in both the pathogenesis and progression of bronchiectasis. Neutrophils release neutrophil serine proteases (NSPs), such as neutrophil elastase (NE), cathepsin G and proteinase 3. When chronically high levels of free NSP activity exceed those of protective antiproteases, structural lung destruction, mucosal-related defects, further susceptibility to infection and worsening of clinical outcomes can occur. Despite the defined role of prolonged, high levels of NSPs in bronchiectasis, no drug that controls neutrophilic inflammation is licensed for the treatment of bronchiectasis. Previous methods of suppressing neutrophilic inflammation (such as direct inhibition of NE) have not been successful; however, an emerging therapy designed to address neutrophil-mediated pathology, inhibition of the cysteine protease cathepsin C (CatC, also known as dipeptidyl peptidase 1), is a promising approach to ameliorate neutrophilic inflammation, since this may reduce the activity of all NSPs implicated in bronchiectasis pathogenesis, and not just NE. Current data suggest that CatC inhibition may effectively restore the protease-antiprotease balance in bronchiectasis and improve disease outcomes as a result. Clinical trials for CatC inhibitors in bronchiectasis have reported positive phase III results. In this narrative review, we discuss the role of high NSP activity in bronchiectasis, and how this feature drives the associated morbidity and mortality seen in bronchiectasis. This review discusses therapeutic approaches aimed at treating neutrophilic inflammation in the bronchiectasis lung, summarising clinical trial outcomes and highlighting the need for more treatment strategies that effectively address chronic neutrophilic inflammation in bronchiectasis.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.005
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow), Research integrity, Insufficient payload (model declined to judge)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.946
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0050.001
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0020.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0010.001
Research integrity0.0000.007
Insufficient payload (model declined to judge)0.0000.004

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.133
GPT teacher head0.430
Teacher spread0.297 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations51
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueEuropean Respiratory JournalSame topicNeonatal Respiratory Health ResearchFrench-language works237,207